West Pharmaceutical Services Inc. buy UBS Group AG
Start price
25.07.25
/
50%
€226.50
Target price
25.07.26
€272.54
Performance (%)
15.32%
Price
24.04.26
€261.20
Summary
This prediction is currently active. The prediction currently has a performance of 15.32%. This prediction currently runs until 25.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| West Pharmaceutical Services Inc. | 12.296% | 12.296% |
| iShares Core DAX® | -1,74 % | 5,98 % |
| iShares Nasdaq 100 | 2,81 % | 11,83 % |
| iShares Nikkei 225® | -0,11 % | 11,69 % |
| iShares S&P 500 | 0,97 % | 7,62 % |
Comments by UBS_Group_AG for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at UBS Group AG from $285.00 to $320.00. They now have a "buy" rating on the stock.
Ratings data for WST provided by MarketBeat
Stopped prediction by UBS_Group_AG for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€208.70
13.02.26
13.02.26
-
13.02.27
13.02.27
25.16%
24.04.26
24.04.26
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€310.00
12.12.24
12.12.24
€372.22
12.12.25
12.12.25
-27.03%
13.12.25
13.12.25